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Vitamin B12 is one of the essential vitamins affecting various systems of the body. Reports of psychiatric disorders
due to its deficiency mostly focus on middle aged and elderly patients. Here we report a case of vitamin B 12
deficiency in a 16-year old, male adolescent who presented with mixed mood disorder symptoms with psychotic
features. Chief complaints were “irritability, regressive behavior, apathy, crying and truancy” which lasted for a year.
Premorbid personality was unremarkable with no substance use/exposure or infections. No stressors were present.
The patient was not vegetarian. Past medical history and family history was normal. Neurological examination
revealed glossitis, ataxia, rigidity in both shoulders, cog-wheel rigidity in the left elbow, bilateral problems of
coordination in cerebellar examination, reduced swinging of the arms and masked face. Romberg’s sign was
present. Laboratory evaluations were normal. Endoscopy and biopsy revealed atrophy of the gastric mucosa
with Helicobacter Pylori colonization. Schilling test was suggestive of malabsorbtion. He was diagnosed with
Mood disorder with Mixed, Psychotic Features due to Vitamin B12 Deficiency and risperidone 0.5 mg/day and
intramuscular vitamin B12 500 mcg/day were started along with referral for treatment of Helicobacter pylori. A visit
on the second week revealed no psychotic features. Romberg’s sign was negative and cerebellar tests were normal.
Extrapyramidal symptoms were reduced while Vitamin B12 levels were elevated. Risperidone was stopped and
parenteral Vitamin B12 treatment was continued with monthly injections for 3 months. Follow-up endoscopy and
biopsy at the first month demonstrated eradication of H. pylori. He was followed monthly for another 6 months
and psychiatric symptoms did not recur at the time of last evaluation. Despite limitations, this case may underline
the observation that mood disorders with psychotic features especially with accompanying extrapyramidal
symptoms lacking a clear etiology may be rare manifestation of vitamin B12 and/or folate deficiency in children
and adolescents and be potentially amenable to treatment.
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Vitamin B12 is one of the essential vitamins affecting vari-
ous systems of the body. In case of deficiency; hematologic
(megaloblastic, macrocytic anemia), neurologic (demyelini-
zation, paresthesia), gastrointestinal (anorexia, glossitis)
as well as psychiatric symptoms arise. The psychiatric
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The symptoms may include agitation, irritability, negativ-
ism, confusion, disorientation, amnesia, impaired con-
centration and attention and insomnia; while psychiatric
disorders that may be diagnosed in patients having vita-
min B12 deficiency include depression, bipolar disorder,
panic disorder, psychosis, phobias and dementia [1-6].
In adult patients, the clinical picture may especially involve
affective or psychotic symptoms. These observations may
be explained by the importance of vitamin B 12, folate and
homocysteine in carbon transfer metabolism (methylation)
required for the production of serotonin, other monoamine
neurotransmitters and catecholamines [1-6]. Up to now,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ciency mostly focused on middle aged and elderly patients
and pediatric cases are reported to be rare [7-9]. This
study aimed to report a case of vitamin B 12 deficiency in
an adolescent who presented with mixed mood disorder
symptoms with psychotic features.
Case presentation
A sixteen-year old male adolescent was brought to our
department with complaints of “irritability, regressive
behavior, apathy, crying and truancy”. Upon questioning
of his parents it was learned that the complaints have
been present for the past year. The patient had started
to display anxiety during separation from his mother,
wept frequently and complained of vague pains, lethargy,
forgetfulness and reduced concentration alternating with
racing thoughts, irritability, anhedonia, distractibility,
reduced sleep and appetite. Speech was reduced and he
became progressively isolated from his peers. He refused
to go to school and when sent became truant frequently.
His parents reported that he was frequently agitated,
spent his free time in front of his computer and that he
ran excessive debts on their credit cards buying items
on-line. There was no previous history of compulsive
shopping or buying sprees. Premorbid personality of the
adolescent was described as extrovert, euthymic and
active. He was well liked by his friends although the aca-
demic staff reported problems in attention starting from
the second grade. His teachers also reported fidgetiness
and impulsivity which was especially prominent in math-
ematics lessons.
In the mental status examination, impaired attention,
concentration, as well as insomnia, reduced working and
short-term memory, elementary auditory (i.e. knocking
and ringing), olfactory (i.e. burnt rubber, perfumes and
tobacco), and visual hallucinations (i.e. a white, man-like
shape, especially present in the evenings), as well as pas-
sive suicidal ideation were noted. Judgment, abstract
thought and reality testing were impaired. Speech was
hypo-phonic, thought process was sluggish. Thought
content was found to be impoverished and dominated
by somatic complaints, delusions of reference, guilt and
thought broadcasting. Mood was blunted and the affect
was restricted in range. Psychomotor activity and appe-
tite were reduced.
The patient reported that those complaints arose in
the past year and that hallucinations were added in the
past three months. Within the last month, delusions
of reference (i.e. thinking that others were looking
at and talking about him), delusions of guilt (i.e. that
he had sinned and would be punished) arose and the
patient reported that his thoughts were broadcast so
that others can read and understand his thoughts.
No history of psychoactive substance use, encephalitis,use of antipsychotics/antiemetics, exposure to carbon-
monoxide or organophosphate compounds or stressors
was present. The patient was not vegetarian. Past med-
ical history and family history was unremarkable for
both psychopathology and chronic medical disorders.
Physical and neurological examination revealed glossitis,
ataxia, rigidity in both shoulders, cog-wheel rigidity in
the left elbow, bilateral problems of coordination in
cerebellar examination, reduced swinging of the arms
and masked face. Romberg’s sign was present although
no signs or symptoms of peripheral neuropathy could be
observed. Evaluation with The Extrapyramidal Symptom
Rating Scale (ESRS) yielded a score of 19, with items of
bradykinesia and parkinsonism being positive [10].
Electroencephalography, electromyography, somato-
sensorial evoked potentials, cerebrospinal fluid analysis,
cranial MRI, thyroid and liver function tests, pancreatic
enzymes, electrolytes, parathormone, ceruloplasmin and
whole blood count were within normal limits. HIV
(ELISA) was negative. Twenty-four hour urine copper
level was within normal ranges. An ophthalmologic
examination ruled out the presence of a Kayser Fleischer
ring. A peripheral blood smear with Wright’s stain
was found to be normal. Endoscopy revealed atrophy
of the gastric mucosa while a biopsy sample taken dur-
ing endoscopy revealed colonization with Helicobacter
Pylori. A Schilling test was administered to determine
the etiology of Vitamin B12 deficiency and it was
observed that radiolabeled Vitamin B12 levels were low
both for Stage I and II of the test which was thought to
reflect malabsorbtion [11].
Psychometric testing with the Beck Depression (BDI)
and Anxiety Inventories (BAI) revealed scores of 35
(Cut-off score = 17, Severe Depressive Symptoms) and
36 (Without a clinically defined cut-off score albeit
denoting severe anxiety), respectively [12,13]. An evalu-
ation with the Turkish version of the Young Mania
Rating Scale (YMRS), which does not have clinically
designated cut-off score, yielded a score of 13 [14].
Psychotic symptoms were evaluated with Positive and
Negative Syndrome Scale and the patient scored 20, 23
and 56 for the Positive, Negative and General Psycho-
pathology subscales (Total 99) [15]. Vitamin B 12 levels
were found to be 166 ng/mL in two subsequent tests
after 6–8 hours of fasting with immunoassay method via
Advia Centaur XTTM (Normal 197–400 ng/mL) while fol-
ate and transcobalamine levels were normal. Hemoglobin
was found to be 10 g/dL (Normal 14–18 g/dL) and MCV
was 98 fL (Normal 80- 100 fL) [16]. Bone marrow exam-
ination did not reveal megaloblastic changes.
As a result of the history and evaluations and noting
that the psychotic symptoms were superimposed on
affective-anxious symptoms, the patient was diagnosed
as having Mood disorder with Mixed, Psychotic Features
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criteria and risperidone 0.5 mg/day and intramuscular
vitamin B12 500 mcg/day were started for treatment
[17]. Risperidone was chosen because of it being one of
the most commonly used atypical antipsychotics for
management of psychosis, pervasive developmental dis-
orders, mental retardation, mood disorders and disrup-
tive behavior disorders in children and adolescents and
having no known interaction with vitamin B12. The
usual dose range of risperidone for acute psychosis and
mood disorder is reported to be 2–8 mg/day while we
have started risperidon at 0.5 mg/day to help stabilize
the patient while the medical work-up and treatments
were being completed [18]. Vitamin B12 was the only
vitamin supplement started.
At the same time the patient was referred for treat-
ment of Helicobacter pylori and was prescribed clari-
thromycin 1000 mg/day, lansoprazole 60 mg/day and
amoxicillin 2000 mg/day. A follow-up visit on the sec-
ond week revealed that no psychotic features were
present, Romberg’s sign was negative and that cerebellar
tests were within normal limits. Extrapyramidal symp-
toms were reduced. Both the patient and his mother
reported that apathy, crying, regressive behavior and tru-
ancy were reduced. An evaluation with BDI and BAI
revealed scores of 9 and 15, respectively while Evaluation
with ESRS and YMRS yielded a score of 3 for both.
PANSS scores for positive, negative and general psycho-
pathology subscales were 13, 15 and 36 respectively
(Total 64). Vitamin B12 levels were measured at this
visit as 595 ng/mL. At the scond week, risperidone was
stopped and parenteral Vitamin B12 treatment was con-
tinued with monthly injections for 3 months. The time
course of changes in BDI, BAI, PANSS and its subscales,
YMRS and ESRS according to Vitamin B12 levels is illu-
strated in Figure 1.Figure 1 Vitamin B12 levels of the patient at baseline, 2nd, 4th,
8th, 12th and 24th weeks compared to changes in psychometric
tests.A follow-up endoscopy and biopsy at the first month
revealed that H. pylori were eradicated from the gastric
mucosa. The patient was followed for another 6 months
at monthly intervals and the psychiatric symptoms did
not recur at the time of last evaluation.
This study reports a case of vitamin B12 deficiency in
an adolescent who presented with mixed mood disorder
symptoms with psychotic features as well as extra-
pyramidal symptoms and its response to Vitamin B12
treatment. Although concurrent administration of ris-
peridone in our patient may be considered as a limita-
tion in light of reports of improvement in psychotic
symptoms as early as the first week, the fact that the
administered dose of 0.5 mg/day was lower than doses
recommended for controlling acute psychosis and mood
disorders may support the beneficial effect of treatment
with Vitamin B12 [18]. The course of improvement in
psychometric measures with changes in Vitamin B12
levels may also support this hypothesis (Figure 1).
Up to now, there was only one case report of psych-
otic disorder, again concomitant with extrapyramidal
symptoms associated with Vitamin B12 and folate defi-
ciency in a 12-year old male adolescent and this case
was also reported from Turkey [8]. The time course and
response to treatment as well as the content of the
symptoms of the patient reported by Dogan and collea-
gues [8] seems to be similar to our patient and although
the folate levels in our patient were within normal limits
it may be argued that vitamin B12 deficiency may have
masked concurrent folate deficiency in our patient.
It is also unclear why Vitamin B12 deficiency leads
to prominent neuro-psychological symptoms in some
patients and not others. C677T polymorphism of the
methylene-tetrahydro folate reductase (MTHFR) gene,
which has an elevated prevalence in Mediterranean
countries, may protect patients defective for Vitamin
B12 levels against the emergence of hematological symp-
toms and homozygosity for this gene may be elevated
in Turkish populations, especially from Eastern Turkey
[1,8,19].
Another interesting feature of both our patient and
that reported by Dogan and colleagues seem to be the
prominence of extra-pyramidal symptoms in presenta-
tion [8]. This may be due to the dissociation between
neurological and hematological symptoms, presumably
due to MTHFR polymorphism or alternatively it may
be due to changes in basal ganglia, especially globus pal-
lidus as observed in Methly-malonic academia [20]. It
may also be posited that patients with less severe muta-
tions of methyl-malonyl coA mutase may be asymptom-
atic initially and reduced activity of the enzyme, perhaps
in situations of vitamin B12 deficiency may lead to
changes in basal ganglia [20]. It may also be striking that
both our patient and the other, two cases of vitamin B12
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[8,20]. Although the lack of evaluation of volumes of
basal ganglia in our patient may also be a limitation of
our study, it may be said that future studies evaluating
volumes of basal ganglia in patients with Vitamin B12
deficiency are needed.
The pathophysiology of extrapyramidal symptoms
in patients with Vitamin B12 deficiency is far from
clear, although some indirect evidence exists. Firstly,
S-Adenosylmethionine (SAM) in carbon transfer metab-
olism is the only methyl donor in the Central Nervous
System and knockout mice for the MTHFR enzyme have
been reported to have reduced SAM, global DNA hypo-
methlyation and cerebellar pathology [21]. Secondly,
cysteine which is a precursor for the major intracellular
redox buffer glutathione is a breakdown product of
homocysteine and therefore the carbon transfer metabol-
ism. Neurons lack this pathway and are dependent on
glia for production, thereby rendering them more sus-
ceptible to oxidative damage [1]. The facts that MDA
(malondialdehyde) is a measure of membrane lipid per-
oxidation and that MMA (methyl malonic academia)
is an inborn error of metabolism usually presenting
with acute extrapyramidal symptoms in infants some-
times responds to vitamin B12 treatment also support
the importance of vitamin B12 in preventing oxidative
damage, perhaps especially for dopaminergic neurons
[1,8,22]. Thirdly, MTHFR is also involved in the metab-
olism of tetrahydrobiopterin and the latter is required for
synthesis of dopamine and serotonin. It also acts directly
on specific membrane receptors to release monoamine
neurotransmitters as well as having specific protective
antioxidant effects on dopamine neurons [1]. Dopamine
also stimulates methylation of phospholipids in the neur-
onal membrane and this reaction depends on single car-
bon folate pathway, thereby underlining the importance
of the relationship between dopaminergic neurotrans-
mission and single carbon metabolism [23]. Lastly, the
cholinergic synapses may also be involved in the patho-
physiology because of the dependence of choline synthe-
sis on SAM [1]. Globus pallidus among the basal ganglia
may be expecially vulnerable to these pathophysiological
mechanisms [20]. Regardless of the pathophysiological
mechanism involved, further studies involving larger
samples are needed to determine the prevalence of extra-
pyramidal symptoms in vitamin B 12 deficient patients
from varying age cohorts.
Conclusions
This study reports a case of vitamin B12 deficiency in an
adolescent male presenting with mood disorder with
mixed features. The lack of evaluation of volumes of
specific brain structures, concurrent administration of
an atypical antipsychotic along with vitamin B12, furtherevaluation of small intestine flora to determine the
causes of bacterial over growth other than H. pylori,
evaluation of RBC folate levels along with levels in
serum of patient, evaluation of Homocysteine levels and
testing for mutations in MTHFR and methyl-malonyl
coA mutase, celiac antibodies and anti-parietal cell titres
may be counted among the limitations of the case pres-
entation. Also, we could neither explain the reduction
in Hb in absence of bone marrow RBC precursor mega-
loblastosis nor the rarity of this presentation in face of
prevelance of mutations in MTHFR/borderline low Hb
and Vitamin B12 levels or the presence of Romberg Sign
along with extrapyramidal symptoms and therefore the
observed presentation may be deemed spurious.
Regardless of its limitations, our case may underline
the observation that mood disorders with psychotic fea-
tures especially with accompanying extrapyramidal
symptoms lacking a clear etiology may be rare manifest-
ation of vitamin B12 and/or folate deficiency in children
and adolescents and be potentially amenable to treat-
ment. Evaluation of Vitamin B12 and folate levels may
be prudent in children and adolescents with affective
complaints of abrupt onset and with accompanying
psychotic/motor features.
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